Equities

Auxly Cannabis Group Inc

Auxly Cannabis Group Inc

Actions
  • Price (EUR)0.0323
  • Today's Change0.002 / 5.90%
  • Shares traded10.00k
  • 1 Year change+289.16%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 20:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments161515
Total Receivables, Net171831
Total Inventory315459
Prepaid expenses1.011.537.05
Other current assets, total1.071.606.45
Total current assets6690119
Property, plant & equipment, net159195226
Goodwill, net--024
Intangibles, net304574
Long term investments1.101.093.90
Note receivable - long term------
Other long term assets3.980.091.58
Total assets262332450
LIABILITIES
Accounts payable------
Accrued expenses0.240.210
Notes payable/short-term debt000
Current portion long-term debt/capital leases655921
Other current liabilities, total0.260.500.80
Total current liabilities1079353
Total long term debt94135169
Total debt159194190
Deferred income tax8.131118
Minority interest0(4.72)(4.41)
Other liabilities, total1.897.423.30
Total liabilities211241238
SHAREHOLDERS EQUITY
Common stock447445437
Additional paid-in capital------
Retained earnings (accumulated deficit)(366)(324)(198)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(30)(31)(26)
Total equity5190213
Total liabilities & shareholders' equity262332450
Total common shares outstanding1,006906844
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.